Further analysis of transcription factors indicated that AKT1 might regulate gluconeogenesis and glycolysis by controlling the phosphorylation of FOXO1 in PUC, while JUN might regulate the EMT and immune by regulating the downstream target genes of JUN in CIS. The gene discussed is FOXO1; the disease is in situ carcinoma.